SHILPA MEDICARE
Back to Balance Sheet
|
SHILPA MEDICARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-13 Cr | ₹-10 Cr | ₹14 Cr | ₹55 Cr | ₹47 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHILPA MEDICARE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-13 Cr |
| Mar2024 | ₹-10 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹47 Cr |
How is Deferred Tax Assets / Liabilities of SHILPA MEDICARE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-13 Cr | Negative | |
| Mar2024 | ₹-10 Cr | Negative | |
| Mar2023 | ₹14 Cr | -74.33 | |
| Mar2022 | ₹55 Cr | 15.77 | |
| Mar2021 | ₹47 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SHILPA MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHILPA MEDICARE | ₹9,626.5 Cr | 3.6% | 18.5% | 37.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
SHILPA MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHILPA MEDICARE | 3.6% |
18.5% |
37.4% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses